NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Sometimes what large pharma companies seem to allow is for a small company to uplist and raise its price by a certain amount after (or concurrent with) TLD in order that the inevitable buyout offer becomes a more reasonable premium. It just seems to work out like that. Here, it seems NWBO and/or BP(s) willingly shackled NWBO’s price per share until such time that irrefutable proof is presented. Thus you have DI actually saying the price per share got ahead of itself when it rose to 2.50. Obviously, the shackles were still on then, and clearly appear to remain for now. IMHO that’s the only thing that makes sense when DI actually frowns on price per share increase early on in his stint at NWBO.